Ameritas Investment Partners’s vTv Therapeutics VTVT Stock Holding History

Ameritas Investment Partners’s Portfolio VTVT Stock Details VTVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-21	Closed	-$2K	–	3236
2021 Q1	$2K	Hold	21	–	–	﹤0.01%	3080
2020 Q4	$2K	Hold	21	–	–	﹤0.01%	3050
2020 Q3	$2K	Hold	21	–	–	﹤0.01%	3074
2020 Q2	$2K	Buy	+21	New	+$2.07K	﹤0.01%	3043
2018 Q2	–	Sell	-13	Closed	-$2K	–	3065
2018 Q1	$2K	Hold	13	–	–	﹤0.01%	2934
2017 Q4	$3K	Hold	13	–	–	﹤0.01%	2920
2017 Q3	$2K	Hold	13	–	–	﹤0.01%	2971
2017 Q2	$2K	Hold	13	–	–	﹤0.01%	2985
2017 Q1	$3K	Buy	+13	New	+$2.96K	﹤0.01%	2904

Other funds holding VTVT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WAG

Winthrop Advisory Group Boston, Massachusetts $1.48B AUM 22.62% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ameritas Investment Partners's VTVT Position: Q2 2021 in Review

Ameritas Investment Partners sold out of vTv Therapeutics (VTVT) in Q2 2021, closing a stake of 21 shares — an estimated $2K sold.

Ameritas Investment Partners first reported a position in VTVT in Q1 2017 and held it in 9 quarters. The position peaked at $3K in Q4 2017. 42 funds tracked by Wall St. Rank hold VTVT as of Q2 2021.

Ameritas Investment Partners reported no remaining vTv Therapeutics position as of Q2 2021 after selling out during the quarter.
Ameritas Investment Partners sold 21 vTv Therapeutics shares in Q2 2021, an estimated $2K.
Ameritas Investment Partners first reported a position in vTv Therapeutics in Q1 2017 and held it in 9 quarters.
Ameritas Investment Partners's vTv Therapeutics position peaked at $3K in Q4 2017.
42 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2021.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.